Health Canada approved the bivalent COVID-19 vaccine for use as a booster dose in individuals 18 years of age or older,
![Second Bivalent COVID-19 Booster Targeting Omicron Variants Approved Second Bivalent COVID-19 Booster Targeting Omicron Variants Approved](https://images.medindia.net/health-images/1200_1000/covid-19-immunity-increases-with-breakthrough.jpg)
Bivalent COVID-19 Booster
This adapted vaccine has a similar safety profile to the previously approved Moderna Spikevax boosters, with the same mild adverse reactions that resolved quickly, Health Canada said. Keeping COVID-19 vaccinations up-to-date, including getting booster doses as recommended, will help protect an individual against serious illness and other complications of the infection, Health Canada said.‘The bivalent COVID-19 vaccine triggers a strong immune response against both Omicron (BA.4/BA.5) and the original SARS-CoV-2 virus strains.’
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
The number of total COVID-19 cases and deaths have now reached 4,336,860 and 46,389, respectively, according to the weekly update issued by the Public Health Agency of Canada. ![twitter](https://images.medindia.net/icons/news/social/twitter.png)
![facebook](https://images.medindia.net/icons/news/social/facebook.png)
![whatsapp](https://images.medindia.net/icons/news/social/whatsapp.png)
![linkedin](https://images.medindia.net/icons/news/social/linkedin.png)
![pinterest](https://images.medindia.net/icons/news/social/pinterest.png)
According to the agency, the cumulative people who had received at least one dose of a COVID-19 vaccine in Canada was 83 percent.
However, those who had in the last six months completed the primary series or received a booster dose with a COVID-19 vaccine in Canada was only 17.2 percent.
Source-IANS